Genetic stability of a dengue vaccine based on chimeric yellow fever/dengue viruses (Q40318846)

19 September 2017

Genetic stability of a dengue vaccine based on chimeric yellow fever/dengue viruses (English)

1 reference

19 September 2017

0 references

0 references

N Mantel

1

1 reference

19 September 2017

Y Girerd

2

1 reference

19 September 2017

C Geny

3

1 reference

19 September 2017

I Bernard

4

1 reference

19 September 2017

J Pontvianne

5

1 reference

19 September 2017

J Lang

6

1 reference

19 September 2017

V Barban

7

1 reference

19 September 2017

language of work or name

English

0 references

publication date

13 July 2011

1 reference

19 September 2017

1 reference

19 September 2017

29

1 reference

19 September 2017

38

1 reference

19 September 2017

6629-6635

1 reference

Live-attenuated, tetravalent dengue vaccine in children, adolescents and adults in a dengue endemic country: randomized controlled phase I trial in the Philippines

19 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.101

Live-attenuated Tetravalent Dengue Vaccine in Dengue-naïve Children, Adolescents, and Adults in Mexico City: Randomized Controlled Phase 1 Trial of Safety and Immunogenicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.101

Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.101

Construction, safety, and immunogenicity in nonhuman primates of a chimeric yellow fever-dengue virus tetravalent vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.101

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.101

The use of yellow fever virus modified by in vitro cultivation for human immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.101

High stability of yellow fever 17D-204 vaccine: a 12-year restrospective analysis of large-scale production.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.101

Fatal viral encephalitis following 17D yellow fever vaccine inoculation. Report of a case in a 3-year-old child

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.101

High fidelity of yellow fever virus RNA polymerase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.101

Standardized quantitative RT-PCR assays for quantitation of yellow fever and chimeric yellow fever-dengue vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.101

Viremia and immunogenicity in nonhuman primates of a tetravalent yellow fever-dengue chimeric vaccine: genetic reconstructions, dose adjustment, and antibody responses against wild-type dengue virus isolates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.101

A novel tetravalent dengue vaccine is well tolerated and immunogenic against all 4 serotypes in flavivirus-naive adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.101

Comparison of the genomes of the wild-type French viscerotropic strain of yellow fever virus with its vaccine derivative French neurotropic vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.101

Long-term transmission of defective RNA viruses in humans and Aedes mosquitoes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.101

Adaptation of two flaviviruses results in differences in genetic heterogeneity and virus adaptability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.101

Live attenuated chimeric yellow fever dengue type 2 (ChimeriVax-DEN2) vaccine: Phase I clinical trial for safety and immunogenicity: effect of yellow fever pre-immunity in induction of cross neutralizing antibody responses to all 4 dengue serotypes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.101

Evaluation of interferences between dengue vaccine serotypes in a monkey model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.101

The flavivirus precursor membrane-envelope protein complex: structure and maturation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.101

Complete nucleotide sequence of yellow fever virus vaccine strains 17DD and 17D-213.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.101

Nucleotide sequence comparison of the genome of two 17D-204 yellow fever vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.101

Genetic variability among yellow fever virus 17D substrains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.101

Comparison of the virulent Asibi strain of yellow fever virus with the 17D vaccine strain derived from it.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.101

Mutations which enhance the replication of dengue virus type 4 and an antigenic chimeric dengue virus type 2/4 vaccine candidate in Vero cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.101

Molecular basis for adaptation of a chimeric dengue type-4/Japanese encephalitis virus to Vero cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.101

A single amino acid substitution in the envelope protein of chimeric yellow fever-dengue 1 vaccine virus reduces neurovirulence for suckling mice and viremia/viscerotropism for monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.101

Substitution of wild-type yellow fever Asibi sequences for 17D vaccine sequences in ChimeriVax-dengue 4 does not enhance infection of Aedes aegypti mosquitoes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.101

Nucleotide sequence of yellow fever virus: implications for flavivirus gene expression and evolution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.06.101

10.1016/J.VACCINE.2011.06.101

7 January 2021

Identifiers

DOI

1 reference

release_jgu6crmfdnd4zjcnt6lt4lsuq4

19 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/jgu6crmfdnd4zjcnt6lt4lsuq4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference